Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VX-548 Phase 2 Study for Acute Pain After Bunionectomy
NCT04977336Phase 2Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Jul 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of suzetrigine in acute pain, sponsored by Vertex Pharmaceuticals. Started Jul 2021; status: completed.
02
Drugs
suzetrigine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT04977336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04977336.